Knight Therapeutics Inc.

TSX:GUD.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$11.56 +0.75%

+$0.07 today

Market cap
$1.14B
Beta
0.07
P/E (TTM)
164.6
EPS (TTM)
$0.06
52W Low $5.66High $9.59

Volume 0.04M

Average 0.10M

GUD.TO Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Knight Therapeutics Inc.TSX: GUD.TO

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings rises 2.6% from a year ago

Retained earnings stood at CA$160.84M at the end of Q1 FY2026, up 2.6% from a year earlier and up 8.0% from the prior quarter. Over 3 fiscal years it compounded at -2.7% a year.

Context

  • Retained earnings amounted to 14.8% of total assets at the end of Q1 FY2026, down 0.8 pp from a year earlier.
  • Retained earnings increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps rising in the next quarterly balance sheet after a +2.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$160.84M+8.0% QoQ
Last fiscal yearDec 2025
CA$148.94M-3.8% YoY
Year agoMar 2025
CA$156.81M+2.6% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.6%——
1 year-3.8%——
3-year CAGR-2.7%——
5-year CAGR——
10-year CAGR——

Retained Earnings history

CAD · from the balance sheet

Latest · FY2025
148.94M CAD
Year-over-year change
-3.8%
4-year CAGR
-6.1%

Retained Earnings vs competitors

How GUD.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +2.6% is the 3rd highest of 8, against a peer median of -1.9%.
  • Retained earnings amounts to 14.8% of total assets for GUD.TO, versus a peer median of 113.1%.
GUD.TO Competitors
Retained Earnings for GUD.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GUD.TOKnight Therapeutics Inc.Mar 2026CA$160.84M CAD+2.6%-2.7%14.8%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$106.35M USD+32.5%+25.5%69.3%
VHI.TOVitalhub Corp.Mar 2026CA$8.02M CAD+1020.6%—2.2%
KSI.TOKneat.com, Inc.Mar 2026-CA$85.32M CAD-11.0%—61.6%
OGI.TOOrganiGram Holdings Inc.Mar 2026-CA$589.68M CAD-4.5%—113.1%
TSND.TOTerrAscend Corp.Mar 2026-$874.42M USD-10.4%—159.1%
ACB.TOAurora Cannabis Inc.Mar 2026-CA$6.44B CAD-1.2%—1071.7%
WEED.TOCanopy Growth CorporationMar 2026-CA$11.14B CAD-1.9%—995.6%
Peer median (excluding GUD.TO) —-1.9%+25.5%113.1%

Competitors are the stored peer set for GUD.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents85.96M71.68M58.76M80.11M76.45M
Short-term Investments77.03M119.54M95.66M92.73M18.83M
Net Receivables67.41M108.57M98.23M113.53M138.24M
Inventory72.4M92.49M91.83M102.7M135.87M
Other Current Assets2.35M19.29M15.75M14.02M18.95M
Total Current Assets307.32M395.62M365.12M396.81M394.84M
Property, Plant & Equipment (Net)29.94M22.63M17.86M20.02M21.93M
Goodwill75.4M82.27M79.84M86.48M89.98M
Intangible Assets350.3M338.78M289.96M283.61M379.51M
Long-term Investments178.95M158.02M120.02M103.43M124.24M
Tax Assets2.05M9.31M19.39M21.25M26.92M
Other Non-current Assets47.93M48.2M53.3M52.2M8.88M
Total Non-current Assets684.57M659.22M580.38M566.98M651.46M
Total Assets991.89M1.05B945.49M963.8M1.05B
Account Payables65.31M106.06M85.37M78.35M120.87M
Short-term Debt26.66M17.67M17.85M17.49M20.13M
Tax Payables7.07M2.27M1.18M213K0
Deferred Revenue9.73M0000
Other Current Liabilities1.99M15.01M7.9M1.88M20.29M
Total Current Liabilities105.3M141.32M114.03M111.25M165.26M
Long-term Debt9.27M52.4M44.02M25.9M51.17M
Deferred Tax Liabilities12.37M4.37M2.82M3.84M2.99M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities19.52M25.85M32.26M24.27M52.99M
Total Non-current Liabilities44.57M87.66M84.59M57.44M113.77M
Total Liabilities149.87M228.98M198.62M168.69M279.03M
Common Stock628.85M599.06M540.05M534.27M530.14M
Retained Earnings191.65M161.76M150.89M154.79M148.94M
Accumulated OCI(259K)41.38M29.95M80.22M55.74M
Other Stockholders Equity000117K0
Minority Interest00000
Total Equity842.02M825.86M746.87M795.11M767.27M
Total Debt40.96M77.7M69.09M49.46M77.91M
Net Debt(45.01M)6.02M10.33M(30.65M)1.46M

Knight Therapeutics Inc.

TSX:GUD.TO

Intrinsic Alpha fair value

Locked

Current Price

$11.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.